Ray Sumita

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ray Sumita's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
141.95
Quantity 63,276 -48.7%
Value US$4,270,580
Transaction date
Proposed sale
Price
432.77
Quantity 13,495
Value US$4,640,967
Transaction date
Sale
Price
208.27
Quantity 49,950 +41.4%
Value US$1,823,158
Transaction date
Sale
Price
30.35
Quantity 6,442 -5.2%
Value US$195,515
Transaction date
Sale
Price
29.37
Quantity 2,383 -1.9%
Value US$69,989
Transaction date
Proposed sale
Price
30.14
Quantity 8,829
Value US$266,106
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-14 2026-10-12
S Sale
63,276 -48.7%
141.95
US$4,270,580 		63,276 -48.7% 141.95 US$4,270,580
2026-10-13 2026-10-12
PrS Proposed sale
13,495
432.77
US$4,640,967 		13,495 432.77 US$4,640,967
2026-08-17 2026-08-13
S Sale
49,950 +41.4%
208.27
US$1,823,158 		49,950 +41.4% 208.27 US$1,823,158
2026-08-17 2026-08-13
S Sale
6,442 -5.2%
30.35
US$195,515 		6,442 -5.2% 30.35 US$195,515
2026-08-17 2026-08-13
S Sale
2,383 -1.9%
29.37
US$69,989 		2,383 -1.9% 29.37 US$69,989
2026-08-13 2026-08-13
PrS Proposed sale
8,829
30.14
US$266,106 		8,829 30.14 US$266,106